No restrictions should be placed on future treatment for patients who discontinue DAAs on their first or second attempt. A real world experience from the TraP HepC initiative in Iceland
Published in: | Journal of Hepatology |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
Elsevier BV
2020
|
Subjects: | |
Online Access: | http://dx.doi.org/10.1016/s0168-8278(20)32095-x https://api.elsevier.com/content/article/PII:S016882782032095X?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S016882782032095X?httpAccept=text/plain |
Description not available. |